Literature DB >> 6452123

Interaction of lipoprotein lipase with native and modified heparin-like polysaccharides.

G Bengtsson, T Olivecrona, M Höök, J Riesenfeld, U Lindahl.   

Abstract

1. Lipoprotein lipase (EC 3.1.1.34), which was previously shown to bind to immobilized heparin, was now found to bind also to heparan sulphate and dermatan sulphate and to some extent to chondroitin sulphate. 2. The relative binding affinities were compared by determining (a) the concentration of NaCl required to release the enzyme from polysaccharide-substituted Sepharose; (b) the concentration of free polysaccharides required to displace the enzyme from immobilized polysaccharides; and (c) the total amounts of enzyme bound after saturation of immobilized polysaccharides. By each of these criteria heparin bound the enzyme most efficiently, followed by heparan sulphate and dermatan sulphate, which were more efficient than chondroitin sulphate. 3. Heparin fractions with high and low affinity for antithrombin, respectively, did not differ with regard to affinity for lipoprotein lipase. 4. Partially N-desulphated heparin (40-50% of N-unsubstituted glucosamine residues) was unable to displace lipoprotein lipase from immobilized heparin. This ability was restored by re-N-sulphation or by N-acetylation; the N-acetylated product was essentially devoid of anticoagulant activity. 5. Partial depolymerization of heparin led to a decrease in ability to displace lipoprotein lipase from heparin-Sepharose; however, even fragments of less than decasaccharide size showed definite enzyme-releasing activity. 6. Studies with hepatic lipase (purified from rat post-heparin plasma) gave results similar to those obtained with milk lipoprotein lipase. However, the interaction between the hepatic lipase and the glycosaminoglycans was weaker and was abolished at lower concentrations of NaCl. 7. The ability of the polysaccharides to release lipoprotein lipase to the circulating blood after intravenous injection into rats essentially conformed to their affinity for the enzyme as evaluated by the experiments in vitro.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6452123      PMCID: PMC1162043          DOI: 10.1042/bj1890625

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Stereospecificity of hepatic lipases.

Authors:  B Akesson; S Gronowitz; B Herslöf
Journal:  FEBS Lett       Date:  1976-12-01       Impact factor: 4.124

2.  Comparison of the triglyceride lipase of liver, adipose tissue, and postheparin plasma.

Authors:  J C LaRosa; R I Levy; H G Windmueller; D S Fredrickson
Journal:  J Lipid Res       Date:  1972-05       Impact factor: 5.922

3.  Purification of salt resistant lipase and lipoprotein lipase from human post-heparin plasma.

Authors:  A M Ostlung-Lindqvist; J Boberg
Journal:  FEBS Lett       Date:  1977-11-15       Impact factor: 4.124

4.  Studies of the influence of N-substitution in heparin on its anticoagulant activity.

Authors:  K Nagasawa; T Tokuyasu; Y Inoue
Journal:  J Biochem       Date:  1977-04       Impact factor: 3.387

5.  Heparin-lipoprotein lipase interactions.

Authors:  T Olivecrona; G Bengtsson; S E Marklund; U Lindahl; M Höök
Journal:  Fed Proc       Date:  1977-01

6.  Lipoprotein lipase from bovine milk. Isolation procedure, chemical characterization, and molecular weight analysis.

Authors:  P H Iverius; A M Ostlund-Lindqvist
Journal:  J Biol Chem       Date:  1976-12-25       Impact factor: 5.157

7.  Structural requirements for the interaction of heparin with antithrombin III.

Authors:  J Riensenfeld; M Höök; I Björk; U Lindahl; B Ajaxon
Journal:  Fed Proc       Date:  1977-01

8.  The copolymeric structure of dermatan sulphate produced by cultured human fibroblasts. Different distribution of iduronic acid and glucuronic acid-containing units in soluble and cell-associated glycans.

Authors:  A Malström; I Carlstedt; L Aberg; L A Fransson
Journal:  Biochem J       Date:  1975-12       Impact factor: 3.857

9.  Structure of the antithrombin-binding site in heparin.

Authors:  U Lindahl; G Bäckström; M Höök; L Thunberg; L A Fransson; A Linker
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

10.  Interaction of lipoprotein lipase with heparin-Sepharose. Evaluation of conditions for affinity binding.

Authors:  G Bengtsson; T Olivecrona
Journal:  Biochem J       Date:  1977-10-01       Impact factor: 3.857

View more
  19 in total

1.  Evidence for Two Distinct Binding Sites for Lipoprotein Lipase on Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1).

Authors:  Mart Reimund; Mikael Larsson; Oleg Kovrov; Sergo Kasvandik; Gunilla Olivecrona; Aivar Lookene
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

Review 2.  Structure and function of heparan sulphate proteoglycans.

Authors:  J T Gallagher; M Lyon; W P Steward
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

3.  Effect of protamine on lipoprotein lipase and hepatic lipase in rats.

Authors:  M Hultin; G Olivecrona; T Olivecrona
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

4.  Lipoprotein lipase is a novel amyloid beta (Abeta)-binding protein that promotes glycosaminoglycan-dependent cellular uptake of Abeta in astrocytes.

Authors:  Kazuchika Nishitsuji; Takashi Hosono; Kenji Uchimura; Makoto Michikawa
Journal:  J Biol Chem       Date:  2010-12-21       Impact factor: 5.157

5.  Secretion of lipoprotein lipase from myocardial cells isolated from adult rat hearts.

Authors:  D L Severson; M Lee; R Carroll
Journal:  Mol Cell Biochem       Date:  1988-01       Impact factor: 3.396

6.  Domain structure of endothelial heparan sulphate.

Authors:  A Lindblom; G Bengtsson-Olivecrona; L A Fransson
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

7.  Structure of heparin fragments with high affinity for lipoprotein lipase and inhibition of lipoprotein lipase binding to alpha 2-macroglobulin-receptor/low-density-lipoprotein-receptor-related protein by heparin fragments.

Authors:  A Larnkjaer; A Nykjaer; G Olivecrona; H Thøgersen; P B Ostergaard
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

8.  Studies, with a luminogenic peptide substrate, on blood coagulation factor X/Xa produced by mouse peritoneal macrophages.

Authors:  U Lindahl; S O Kolset; J Bøgwald; B Osterud; R Seljelid
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

9.  Human copper-containing superoxide dismutase of high molecular weight.

Authors:  S L Marklund
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  [Use of low molecular-weight heparin in hemodialysis patients].

Authors:  J Schrader; J Rieger; H Müschen; W Stibbe; H Köstering; P Kramer; F Scheler
Journal:  Klin Wochenschr       Date:  1985-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.